| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/27/2004 | WO2001066563A3 T1r taste receptors and genes encoding same |
| 05/27/2004 | WO2000073764A3 Composition and methods for the therapeutic use of an atonal-associated sequence |
| 05/27/2004 | WO1999046281A8 Novel polypeptides and nucleic acids encoding the same |
| 05/27/2004 | WO1999042077A3 Compositions and methods for regulating lymphocyte activation |
| 05/27/2004 | US20040103455 Comprises nucleotide sequences coding insecticidal protein for generation and propagation of insect resistant plants; biological pest control |
| 05/27/2004 | US20040103453 Lipoxygenase genes, promoters, transit peptides and proteins thereof |
| 05/27/2004 | US20040103452 Increasing proability of asexual reproduction in transgenic plants using nucleotide sequences coding somatic embryogenesis receptor kinase and auxin administration |
| 05/27/2004 | US20040103447 Schizophrenia-like mental disease model animal, method of constructing the same and use thereof |
| 05/27/2004 | US20040102624 Compositions and methods for regulating autolytic processes in bacteria |
| 05/27/2004 | US20040102620 Msh4 gene splicing variant delta |
| 05/27/2004 | US20040102613 For prophylactic/therapeutic drugs for heart/central nervous system diseases; diagnostic kits |
| 05/27/2004 | US20040102612 For diagnosing/treating/preventing disorders; microarrays; drugs; quantitative analysis of toxicity; genetic engineering |
| 05/27/2004 | US20040102611 For treatment of human diseases; drug screening; bllt analysis; genetic engineering; kits |
| 05/27/2004 | US20040102608 Multiblock copolymers having improved mechanical properties |
| 05/27/2004 | US20040102606 Histone H2A -derived peptides useful in gene delivery |
| 05/27/2004 | US20040102605 For prevention/treatment of Pseudomonas infections |
| 05/27/2004 | US20040102571 For minimizing/eliminating self-aggregation; kits |
| 05/27/2004 | US20040102458 Antiproliferative agents; antitumor agents; binding to chaperone protein |
| 05/27/2004 | US20040102411 DNA vaccine against feline immunodeficiency virus |
| 05/27/2004 | US20040102388 Modified blood clotting factors and methods of use |
| 05/27/2004 | US20040102381 Methods of altering the binding affinity of a peptide to its receptor |
| 05/27/2004 | US20040102380 Method for continuous, automated blending of solutions from acids and bases |
| 05/27/2004 | US20040102379 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 05/27/2004 | US20040102378 Peptides as solubilizing excipients for transforming growth factor beta proteins |
| 05/27/2004 | US20040102377 An infant nutritional composition contains a protein with casein rich in transforming growth factor, promoting the antigen tolerance in mouth |
| 05/27/2004 | US20040102376 Use of rgm and its modulators |
| 05/27/2004 | US20040102375 Methods to overcome inhibition of growth cone translocation |
| 05/27/2004 | US20040102373 Protein-induced morphogenesis |
| 05/27/2004 | US20040102372 Therapeutic antiangiogenic compositions and methods |
| 05/27/2004 | US20040102370 Peptides that stimulate cell survival and axon regeneration |
| 05/27/2004 | US20040102364 A radioactive cyclized peptide has chemical and metabolic stability, bioavailability, pharmacokinetics; drugs for treating cancers, autoimmune diseases, endocrine disorders, diabetes, gastrointestinal disorders, inflammatory diseases |
| 05/27/2004 | US20040102363 Substantially pure lectin for prevention and treatment of crustaceous infected by baculovirus, a food composition containing the lectin and a method for increasing the crustaceous resistance to infections |
| 05/27/2004 | US20040101965 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/27/2004 | US20040101963 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus |
| 05/27/2004 | US20040101957 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol.nef and modifications |
| 05/27/2004 | US20040101956 For drug screening kits; therapy/prophylaxis; genetic engineering |
| 05/27/2004 | US20040101946 Method of using ammonia-oxidizing bacteria |
| 05/27/2004 | US20040101940 Identification of a new cytotoxic activity from the ink of aplysia punctata |
| 05/27/2004 | US20040101934 Beverage comprising peptide nerve growth factor conjugate for use in treatment of pain; analgesics; tranquilizers |
| 05/27/2004 | US20040101931 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 05/27/2004 | US20040101930 Polypeptide comprising signal sequences for use in diagnosis, prevention and treatment of nervous system, cell proliferative, autoimmune, inflammatory, cardiovascular and developmental disorders |
| 05/27/2004 | US20040101929 Comprises transgenic yellow grouper brain cell expressing immunoglobulin complex which prevents viral infection in teleost farms; animal husbandry and veterinary medicine |
| 05/27/2004 | US20040101927 Comprises nucleotide sequences coding polypeptides for diagnosis, prognosis, prevention and treatment of neurodegenerative and cancer disorders |
| 05/27/2004 | US20040101919 Detecting cell wall anchored surface proteins and developing vaccines to diagnose, prevent and treat enterococcus, streptococcus, staphylococcus and bacillus infections |
| 05/27/2004 | US20040101916 Using decreased expression of growth arrest and DNA-damage-inducible gene 45 beta (GADD45 beta) to diagnose cirrhosis and liver cancer |
| 05/27/2004 | US20040101910 Immunoglobulin capable of binding lymphocyte polypeptides for treatment and prevention of cell proliferative disorders; antitumor agents |
| 05/27/2004 | US20040101905 Genetically engineered immunoglobulin comprising effector peptide binding site for use in immunodiagnostic imaging |
| 05/27/2004 | US20040101901 Novel lipophilic complexes for insertion of receptors into lipid membranes |
| 05/27/2004 | US20040101899 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/27/2004 | US20040101887 Comprises conjugate beta-arrestin/green fluorescent protein fusion for identifying modulators of g-protein coupled receptor kinases; drug screening; vasodilation and cardiovascular disorders |
| 05/27/2004 | US20040101884 Molecules for disease detection and treatment |
| 05/27/2004 | US20040101882 Secreted proteins |
| 05/27/2004 | US20040101875 Novel g protein-coupled receptor protein and dna thereof |
| 05/27/2004 | US20040101872 Lipocalins |
| 05/27/2004 | US20040101871 Regulation of human gpcr-like protein |
| 05/27/2004 | US20040101864 Chemical process |
| 05/27/2004 | US20040101862 Comprises flaviviral polypeptide for use in the treatment cancer and viral diseases |
| 05/27/2004 | US20040101840 Comprises nucleotide sequences coding acyclovir/gancyclovir/prostate specific protein fusion for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 05/27/2004 | US20040101833 Human TREK2, a stretch- and arachidonic acid-sensitive K+ channel activated by inhalational anesthetics and riluzole |
| 05/27/2004 | US20040101831 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 05/27/2004 | US20040101829 Protein that interacts with lipids and methods for treating hyperlipidemia |
| 05/27/2004 | US20040101821 Antiviral antisense therapy |
| 05/27/2004 | US20040101580 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same |
| 05/27/2004 | US20040101536 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 05/27/2004 | US20040101534 Adjuvant-free peptide vaccine |
| 05/27/2004 | US20040101533 Fusion protein; antitumor, anticancer agenst |
| 05/27/2004 | US20040101531 Prevention of infections; antigen stimulate immunology response; antiulcer agents; cardiovascular disorders |
| 05/27/2004 | US20040101528 Type I IL-1 receptors |
| 05/27/2004 | US20040101525 Heat resistance; controlling Clostridium, Campylobacter, Streptococcus; gastrointestinal disorders; bactericides |
| 05/27/2004 | US20040101522 Transduced neoplastic cell preparations able to express T-cell costimulatory molecules B7.1, ICAM-1, and LFA-3 and induce immunostimulatory prophylactic and therapeutic anti-tumor effects in-vivo |
| 05/27/2004 | US20040101509 Chemokine mutants in the treatment of multiple sclerosis |
| 05/27/2004 | US20040099809 Image intensifying visual scanning device and method |
| 05/27/2004 | DE10253525A1 Diagnosis, prognosis and monitoring of cardiac disease, useful e.g. for selecting therapy, by determining the serum concentration of soluble CD40 ligand, a specific marker for platelet activation |
| 05/27/2004 | DE10147638B4 Leukozyten-Inaktivierungs-Modul (LIM) Leukocyte inactivation module (LIM) |
| 05/27/2004 | CA2813515A1 T cell receptor display |
| 05/27/2004 | CA2757475A1 Compositions and methods for the treatment of natural killer cell related diseases |
| 05/27/2004 | CA2505974A1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same |
| 05/27/2004 | CA2505949A1 Process for designing inhibitors of influenza virus non-structural protein 1 |
| 05/27/2004 | CA2505931A1 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 05/27/2004 | CA2505839A1 A novel pth responsive gene |
| 05/27/2004 | CA2505807A1 Dna sequences from tcd genomic region of photorhabdus luminescens |
| 05/27/2004 | CA2505724A1 Malaria vaccine |
| 05/27/2004 | CA2505558A1 T cell receptor display |
| 05/27/2004 | CA2505551A1 Highly permissive cell lines for hepatitis c virus replication |
| 05/27/2004 | CA2505403A1 Modified dendritic cells |
| 05/27/2004 | CA2505250A1 Acetylated hmgb1 protein |
| 05/27/2004 | CA2505197A1 Use of edg2 receptor in an animal model of heart failure |
| 05/27/2004 | CA2505125A1 Assay for autoantibodies to folate receptors |
| 05/27/2004 | CA2504953A1 A new target for angiogenesis and anti-angiogenesis therapy |
| 05/27/2004 | CA2504947A1 Auxin-repressed, dormancy-associated promoter and uses thereof |
| 05/27/2004 | CA2504903A1 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | CA2504768A1 Compounds and methods for modulating functions of classical cadherins |
| 05/27/2004 | CA2504670A1 Combinatorial libraries of monomer domains |
| 05/27/2004 | CA2504193A1 Enhanced variants of erythropoietin and methods of use |
| 05/27/2004 | CA2503787A1 Methods of isolation of active compounds and activated targets |
| 05/27/2004 | CA2503759A1 Compositions and methods for the treatment of rheumatoid arthritis |
| 05/27/2004 | CA2503748A1 Compositions and methods for the treatment of natural killer cell related diseases |
| 05/27/2004 | CA2503672A1 Growth hormone variations in humans and its uses |
| 05/27/2004 | CA2503303A1 Flavivirus fusion inhibitors |
| 05/26/2004 | EP1422294A1 Method of making an HPV18 L1 Expression Vector and HPV18 L1,L2 antibodies |